William Blair analyst Andy Hsieh initiated coverage of Altimmune (ALT) with a Market Perform rating. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on ALT: Altimmune files $400M mixed securities shelf Altimmune’s Innovative Approach to MASH and Obesity: A Promising Future with Pemvidutide Altimmune Reports 2024 Financial Results and R&D Progress Altimmune reports Q4 EPS (33c), consensus (34c) Altimmune Expands Board Amid Late-Stage Drug Development